Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 6/20 | 0.54 |
| ▸ | NOS1 | P29475 | 4/20 | 0.54 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.54 |
| ▸ | HTR3B | O95264 | 1/20 | 0.54 |
| ▸ | HTR3A | P46098 | 1/20 | 0.54 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.54 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.54 |
| ▸ | NOS2 | P35228 | 2/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.49 |
| ▸ | ACR | P10323 | 1/20 | 0.49 |
| ▸ | PTGIR | P43119 | 1/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5423613 | 0.88 | NOS3 (0.68) | NOS3NOS1HTR3EHTR3BHTR3A | |
| SCHEMBL4863129 | 0.84 | ADRA2A (0.58) | NOS3NOS1PRSS1MAPTPRSS2 | |
| SCHEMBL4853071 | 0.82 | CYP2D6 (0.64) | NOS3NOS1HTR3EHTR3BHTR3A | |
| SCHEMBL4852965 | 0.81 | NOS1 (0.58) | NOS3NOS1MAPTCYP2D6HIF1A | |
| SCHEMBL4857038 | 0.81 | NOS1 (0.58) | NOS3NOS1NOS2CYP2D6HIF1A | |
| SCHEMBL4864124 | 0.81 | NOS3 (0.58) | NOS3NOS1HTR3EHTR3BHTR3A | |
| SCHEMBL5425354 | 0.81 | RAB9A (0.61) | NOS3NOS1HTR3EHTR3BHTR3A | |
| SCHEMBL4856119 | 0.81 | NOS3 (0.58) | NOS3NOS1HTR3EHTR3BHTR3A | |
| SCHEMBL4854767 | 0.81 | NOS1 (0.58) | NOS3NOS1NOS2CYP2D6HIF1A | |
| SCHEMBL11769995 | 0.80 | CYP2D6 (0.66) | NOS3NOS1HTR3EHTR3BHTR3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7365069-B2 | Pyrimidone derivatives | BEXEL PHARMACEUTICALS INC. (US) | 2008-04-29 | — | — | US | disclosed |
| US-20040259891-A1 | Novel pyrimidon derivatives | ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) | 2004-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259891-A1 | Novel pyrimidon derivatives | TYMS, TPMT, TYMP | NOS3 3830/4885NOS1 3074/4885HTR3E 2015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.